GlassScriptPhysician profile
Jennifer E Harper
NPI 1912231143
$9,868.18
in general payments reported to CMS, 2019-2025
46 companies · $6,228 in 2025
The $6,228 reported for 2025 was more than what 98% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
See the full distribution for Acute Care (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $489 · 2022: $880 · 2023: $906 · 2024: $1,365 · 2025: $6,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,549 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,550 · Travel and Lodging: $1,200 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,549.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,550.00 |
| Travel and Lodging | $1,199.93 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $3,864.29 | 2025 | Vyloy |
| Celgene Corporation | $928.75 | 2021-2024 | Reblozyl, Pomalyst |
| Janssen Biotech, INC. | $525.79 | 2024-2025 | Rybrevant, Tecvayli, Talvey |
| Amgen INC. | $399.99 | 2021-2024 | Evenity, Prolia, Nplate |
| Astrazeneca Pharmaceuticals LP | $369.27 | 2021-2025 | Calquence, Tagrisso, Imfinzi |
| Daiichi Sankyo INC. | $359.87 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Regeneron Healthcare Solutions, INC. | $353.37 | 2023-2025 | Libtayo |
| Merck Sharp & Dohme LLC | $312.07 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Beigene USA, INC. | $253.56 | 2023-2025 | Brukinsa |
| Eisai INC. | $218.04 | 2021-2025 | |
| Gilead Sciences, INC. | $190.63 | 2021-2025 | Trodelvy |
| Rigel Pharmaceuticals, INC. | $169.53 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Pfizer INC. | $157.68 | 2021-2025 | |
| Aveo Pharmaceuticals, INC. | $155.78 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $152.68 | 2021-2024 | Opdivo, Krazati, Opdualag |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $147.69 | 2021-2025 | Ninlaro, Iclusig, Fruzaqla |
| Novartis Pharmaceuticals Corporation | $139.45 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $117.52 | 2021-2025 | |
| Puma Biotechnology, INC. | $79.39 | 2024-2025 | |
| Tersera Therapeutics LLC | $75.47 | 2025 | Xermelo, Zoladex |
| Genmab U.S., INC. | $72.79 | 2024-2025 | Epkinly |
| Pharmaessentia USA Corporation | $71.05 | 2024-2025 | Besremi |
| Acrotech Biopharma INC. | $67.06 | 2023-2024 | Beleodaq |
| Coherus Oncology, INC. | $63.78 | 2021 | |
| Pharmacosmos Therapeutics INC. | $54.17 | 2024-2025 | Monoferric |
| Novocure INC. | $52.78 | 2023 | Optune |
| Bayer Healthcare Pharmaceuticals INC. | $50.46 | 2023-2025 | |
| Lilly USA, LLC | $49.41 | 2022-2025 | Jaypirca, Verzenio |
| Incyte Corporation | $44.71 | 2025 | Niktimvo, Jakafi, Monjuvi |
| Blueprint Medicines Corporation | $39.68 | 2024 | Ayvakit |
| Abbvie INC. | $28.31 | 2024 | |
| Taiho Oncology, INC. | $26.13 | 2025 | |
| Nuvation Bio INC. | $23.99 | 2025 | Ibtrozi |
| Emd Serono, INC. | $23.93 | 2025 | |
| Lundbeck LLC | $23.72 | 2022 | |
| Genentech USA, INC. | $21.10 | 2025 | Phesgo |
| Cycle Pharmaceuticals INC | $21.09 | 2025 | Phyrago |
| Sumitomo Pharma America, INC. | $20.41 | 2025 | Orgovyx |
| Geron Corporation | $19.86 | 2025 | Rytelo |
| Beone Medicines USA, INC. | $19.46 | 2025 | Tevimbra |
| Alexion Pharmaceuticals, INC. | $19.12 | 2025 | Ultomiris |
| Adc Therapeutics America, INC. | $17.64 | 2025 | |
| Exelixis INC. | $17.64 | 2024 | Cabometyx |
| Seagen INC. | $17.16 | 2022 | |
| Array Biopharma INC | $16.81 | 2025 | Lorbrena, Braftovi, Mektovi |
| Atricure, INC. | $15.10 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.